US Patent 11266772 Use of heparin and carbohydrates to treat cancer
Patent 11266772 was granted and assigned to ExThera Medical on March, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11266772 Use of heparin and carbohydrates to treat cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
